Filter
773
Text search:
pediatric
HIV
Featured
102
248
Language
Document type
477
107
97
48
16
13
12
2
1
Countries
60
35
28
25
24
18
18
17
14
13
12
10
9
9
9
9
9
9
8
8
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
4
4
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
366
92
64
37
17
15
2
Toolboxes
105
75
31
30
28
28
14
13
10
7
7
7
6
6
5
5
5
4
3
2
2
2
1
1
Psiquiatría y pediatría - Capítulo I.3
El progreso en la prevención y el tratamiento del VIH/SIDA en los últimos veinte años ha sido notable. Una enfermedad que inicialmente dio lugar a una rápida mortalidad se ha convertido en una enfermedad crónica. Tanto es así que un adolescente diagno
...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Equity and Quality in Health: a People's Right
Clinical Infectious Diseases 2010; 50:291–322
A survival guide for clinicans.
3rd edition.
Lessons from the STEP-TB Project.
Accessed November 2017.
Accessed December 2017
Review
Triccas and Counoupas Pneumonia (2016) 8:18; DOI 10.1186/s41479-016-0020-z
Consensus -based guidelines for diagnosis, prevention and treatment of tuberculosis in children and adolescents
East and Central African Journal of Surgery
Association of Surgeons of East Africa and College of Surgeons of East Central and Southern Africa
ISSN: 1024-297X EISSN: 2073-9990
Vol. 16, Num. 1, 2011, pp. 104-110
Данное руководство содержит детальное описание стратегии диагностики и ведения пациентов с лекарственно-устойчивыми формами ТБ, прежде всего с туберкулезом с мн
...
16.7.2021
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
